Trial Profile
Safety of pomalidomide and lenalidomide in patients with multiple myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Sep 2016
Price :
$35
*
At a glance
- Drugs Pomalidomide (Primary) ; Lenalidomide
- Indications Multiple myeloma
- Focus Adverse reactions
- 01 Sep 2016 New trial record